Results 181 to 190 of about 381,135 (230)

Comparison between commercial heparin, low molecular weight heparin and pentosan polysulfate on hemostasis and platelets in vivo.

Thrombosis Research, 1982
C. Esquivel, D. Bergqvist, C. Björck, B. Nilsson   +3 more
semanticscholar   +1 more source

Low Molecular Weight Heparin

Thrombosis and Haemostasis, 1993
openaire   +2 more sources

In Vitro Studies of the Interaction of Heparin, Low Molecular Weight Heparin and Heparinoids with Platelets

Annals of the New York Academy of Sciences, 1989
H. Messmore, B. Griffin, J. Fareed, E. Coyne, J. Seghatchian   +4 more
semanticscholar   +1 more source

Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.

Thrombosis Research, 2008
A. Greinacher, Susanne Alban, M. A. Omer-Adam, Werner Weitschies, Theodore E. Warkentin   +4 more
semanticscholar   +1 more source

Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication.

Cochrane Database of Systematic Reviews, 2001
B. Cosmi, E. Conti, Sergio Coccheri
semanticscholar   +1 more source

Heparin/low-molecular-weight-heparins

Reactions Weekly, 2023
openaire   +2 more sources

Heparin/low molecular weight heparins

Reactions Weekly, 2020
openaire   +1 more source

Effect of nonspecific binding to plasma proteins on the antithrombin activities of unfractionated heparin, low-molecular-weight heparin, and dermatan sulfate.

Circulation, 1997
B. Cosmi, J. Fredenburgh, J. Rischke, J. Hirsh, E. Young, J. Weitz   +5 more
semanticscholar   +1 more source

LOW MOLECULAR WEIGHT HEPARIN(S)

British Journal of Haematology, 1995
openaire   +2 more sources

Low molecular weight heparins

Reactions weekly
David Flaherty, Alekhya Mascarenhas, Radha Sayal, Sobia Khan, Julia E. Moore   +4 more
semanticscholar   +1 more source